Investment Rating - The investment rating for China Tobacco Hong Kong (6055.HK) is not explicitly stated in the provided documents, but the overall performance and future outlook suggest a positive sentiment towards the stock [1]. Core Insights - The company reported a strong annual performance for 2025, achieving revenue of HKD 14.58 billion (up 11.5% year-on-year) and a net profit attributable to shareholders of HKD 980 million (up 21.7 year-on-year), with a net profit margin of 6.7% (up 0.6 percentage points) [1]. - The second half of 2025 saw a revenue of HKD 4.26 billion (down 2.5% year-on-year) and a net profit of HKD 270 million (up 30.2% year-on-year), indicating a recovery in profitability despite a slight decline in revenue [1]. - The company aims to accelerate its global expansion through both organic growth and acquisitions, with expectations for improved profitability driven by product structure optimization and market positioning [4]. Summary by Sections Financial Performance - The company experienced a robust revenue growth of 11.5% year-on-year, with a total revenue of HKD 14.58 billion for 2025. The net profit increased by 21.7% year-on-year to HKD 980 million, reflecting a net profit margin improvement [1][2]. - In the second half of 2025, the revenue was HKD 4.26 billion, showing a slight decline of 2.5% year-on-year, while the net profit surged by 30.2% to HKD 270 million, indicating strong operational efficiency [1][2]. Segment Analysis - **Tobacco Leaf Imports**: Revenue for H2 2025 was HKD 1.14 billion (down 21.5% year-on-year), with a gross margin of 7.5% (up 1.9 percentage points) [2]. - **Tobacco Leaf Exports**: Revenue reached HKD 1.33 billion (up 15.9% year-on-year), with a gross margin of 7.06% (up 2.2 percentage points) [2]. - **Cigarette Exports**: Revenue was HKD 1.11 billion (up 8.6% year-on-year), with a gross margin of 21.4% (up 6.2 percentage points) [3]. - **New Tobacco Exports**: Revenue fell to HKD 50 million (down 45.8% year-on-year), but the decline in sales volume is expected to narrow in the future [3]. - **Brazil Operations**: Revenue was HKD 630 million (down 3.5% year-on-year), with a gross margin of 16.9% (down 0.8 percentage points) [3]. Profit Forecast - The company anticipates net profits of HKD 1.13 billion, HKD 1.39 billion, and HKD 1.61 billion for 2026, 2027, and 2028, respectively, with corresponding price-to-earnings ratios of 23.6X, 19.2X, and 16.6X [4].

Core Viewpoint - The company reported a steady growth in performance for the first half of 2025, with revenue increasing by 18.5% year-on-year and net profit rising by 9.8%, despite fluctuations in profitability due to delivery schedules affecting high-margin businesses [1][2]. Financial Performance - The company achieved a revenue of HKD 10.316 billion for 25H1, with a net profit of HKD 706 million, a gross margin of 9.2%, and a net margin of 6.8% [2]. - The proposed interim dividend is HKD 0.19 per share, with a dividend payout ratio of approximately 19%, an increase from HKD 0.15 per share and a 16% payout ratio in the same period of 2024 [2]. Business Segments - **Tobacco Leaf Imports**: Revenue of HKD 8.399 billion, up 23.5% year-on-year, with a gross margin of 8.18% [2]. - **Tobacco Leaf Exports**: Revenue of HKD 1.156 billion, up 25.9% year-on-year, with a gross margin of 5.46% [2]. - **Cigarette Exports**: Revenue of HKD 552 million, up 0.8% year-on-year, with a gross margin of 25.70% [2]. - **New Tobacco Exports**: Revenue of HKD 15 million, down 66.5% year-on-year, with a gross margin of 5.34% [2]. - **Brazilian Operations**: Revenue of HKD 195 million, down 50.3% year-on-year, with a gross margin of 27.43% [2]. Strategic Outlook - The company is positioned to maintain a stable growth trajectory, supported by strong supply chain management and its unique status as the only enterprise with state-run tobacco import and export qualifications [3].